| scholarly article | Q13442814 |
| P50 | author | Mårten Segelmark | Q48570215 |
| P2093 | author name string | Ulrika Lindberg | |
| Claes-Göran Löfdahl | |||
| Malin Carlsson | |||
| P2860 | cites work | Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. | Q52858669 |
| Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. | Q54520720 | ||
| CFTR Genotype as a Predictor of Prognosis in Cystic Fibrosis | Q56638112 | ||
| Extensive Endoscopic Image-Guided Sinus Surgery Decreases BPI-ANCA in Patients with Cystic Fibrosis | Q59139072 | ||
| Fat-free mass depletion in cystic fibrosis: Associated with lung disease severity but poorly detected by body mass index | Q61654280 | ||
| An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA) | Q68453512 | ||
| Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders | Q71006423 | ||
| Predictors of deterioration of lung function in cystic fibrosis | Q74054944 | ||
| Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies | Q75323045 | ||
| Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease | Q78197160 | ||
| Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis | Q79431179 | ||
| Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients | Q79624986 | ||
| Increased glucose excursion in cystic fibrosis and its association with a worse clinical status | Q80098903 | ||
| The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense | Q28276527 | ||
| Standardization of Spirometry, 1994 Update. American Thoracic Society | Q29547574 | ||
| Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society | Q29616361 | ||
| Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study | Q33966225 | ||
| The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). | Q34635892 | ||
| Cystic fibrosis related diabetes | Q34995370 | ||
| Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. | Q35536317 | ||
| An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. | Q36603406 | ||
| From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). | Q36743368 | ||
| The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. | Q36902238 | ||
| Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis | Q40564213 | ||
| Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes | Q40867899 | ||
| Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis | Q40982307 | ||
| Role of the bactericidal/permeability-increasing protein in host defence. | Q41729809 | ||
| Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition | Q43745855 | ||
| Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis | Q44072286 | ||
| BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro | Q44132289 | ||
| Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis | Q44212013 | ||
| Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis | Q44923126 | ||
| Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis | Q47797303 | ||
| Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis | Q47896778 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 370107 | |
| P577 | publication date | 2012-12-30 | |
| P1433 | published in | Clinical and Developmental Immunology | Q15754140 |
| P1476 | title | BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study | |
| P478 | volume | 2012 |
Search more.